Table 2.
Drug Class/Medications | BCC | SCC | Melanoma |
---|---|---|---|
Diuretics | + (4) | + (7) | + (5) |
CCBs | + (3) | Null (3) | + (5) |
Beta-Blockers | + (3) | Null (3) | Null (3) |
ACEi | Null (2) | Null (2) | Null (5) |
ARB | Null (2) | Null (2) | Null (3) |
Metformin | Null (3) | Null (2) | Null (9) |
Amiodarone | Null (2) | ||
Statins | Null (20) | Null (26) | |
Voriconazole | Null (2) | + (6) | 0 |
Vemurafenib | 0 | + (11) | 0 |
Antibacterial agents | + (3) | + (3) | + (3) |
1 Included medications are those with more than two epidemiological studies. Direction of association: +,-, null (total number of studies described, composite of those included in meta-analyses and individual studies). The cell is marked 0 for medications where no relative epidemiological studies were found.